Search results
Jardiance vs. Farxiga: Similarities and Differences
Verywell Health via Yahoo News· 2 months agoLearn more about the similarities and differences between Jardiance (empagliflozin) and Farxiga (dapagliflozin), two SGLT2 inhibitors used for treating...
FDA Expands Lilly (LLY) Jardiance Label in Chronic Kidney Disease
Zacks via Yahoo Finance· 8 months agoEli Lilly LLY announced that the FDA has expanded the label of its diabetes drug, Jardiance...
Lilly (LLY) Gets FDA Nod for Pediatric Use of Diabetes Drugs
Zacks via Yahoo Finance· 11 months agoFollowing FDA's label expansion approval, Lilly's (LLY) Jardiance and Synjardy are the first SGLT2...
Lilly, Boehringer say Jardiance slows kidney disease progression in trial
Reuters via Yahoo News· 2 years agoBoehringer Ingelheim and Eli Lilly said their diabetes drug Jardiance was shown to slow the...
FDA Approves New Class of Oral Medicines for Children with Type 2 Diabetes
Benzinga via Yahoo Finance· 11 months agoOn Tuesday, the FDA approved Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin...
Could This New Drug Indication Be a Winner for Eli Lilly?
Motley Fool· 1 year agoEli Lilly (NYSE: LLY) and Boehringer Ingelheim's supplemental New Drug Application for Jardiance...
The Zacks Analyst Blog Highlights AbbVie, Lilly, Sanofi, Merck and J&J
Zacks via Yahoo Finance· 8 months agoFor Immediate Release Chicago, IL – October 2, 2023 – Zacks.com announces the list of stocks...
Pharma Stock Roundup: JNJ Q4 Results Mixed, MRK Keytruda Prostate Cancer Study Ends
Zacks via Yahoo Finance· 1 year agoThis week, J&J JNJ began the fourth-quarter earnings season for the drug and biotech sector with...
Eli Lilly's Diabetes Drug Shows Statistical Reduction In Blood Sugar Levels In Children, Adolescents
Benzinga via Yahoo Finance· 1 year agoEli Lilly And Co's (NYSE: LLY) DINAMO Phase 3 trial met its primary endpoint by demonstrating a...
Rubin: Got the hiccups? Helpful readers have dozens of cures.
Gannett via AOL· 4 hours agoSometimes medical breakthroughs come from deep thought and research, and sometimes it's just being a...